Senseonics (NYSE:SENS) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Senseonics (NYSE:SENS – Get Rating) in a report released on Friday. The firm set a “sell” rating on the stock.

Senseonics Price Performance

Shares of NYSE:SENS opened at $0.82 on Friday. The company has a fifty day moving average of $1.16. Senseonics has a fifty-two week low of $0.77 and a fifty-two week high of $2.44. The company has a market capitalization of $394.37 million, a PE ratio of -4.12 and a beta of 0.92. The company has a quick ratio of 2.81, a current ratio of 2.94 and a debt-to-equity ratio of 3.18.

Get Senseonics alerts:

About Senseonics

(Get Rating)

Senseonics Holdings, Inc engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications.

See Also

• Get a free copy of the StockNews.com research report on Senseonics (SENS)
• MarketBeat Week in Review – 3/13 – 3/17
• This Small Tech With Big Growth Prospects Is Nearing A Buy Point
• Don’t Chase FedEx Higher, Wait For The Pullback
• 3 Stocks For A Defensive Tech Portfolio 
• Milk the Dividends on These 3 Cash Cows

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.